Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRESTO:Osteo: IV vs Oral Antibiotics for Osteomyelitis
NCT02099240Phase 1Terminated
- Start
- Mar 2014
- Primary completion
- Nov 2018
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in osteomyelitis (OM) (2 arms). Primary endpoint: Clinical Failures at 12 months. Started Mar 2014; status: terminated.
02
Conditions
osteomyelitis (OM)
Beyond the preview
Go deeper on NCT02099240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02099240.